Çanakkale Onsekiz Mart University   Report issue

Academic/Hospital Phase 4
Founded: Çanakkale Turkey (1992)

Organization Overview

First Clinical Trial
2007
NCT04245774
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Çanakkale Onsekiz Mart University

Active Ingredients

Drugs in Phase 4 Trials (2)

bupivacaine (Exparel) (1 trial)

levobupivacaine (chirocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rectal Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2